SlideShare a Scribd company logo
1 of 1
Download to read offline
The Outermost N-Terminal Region of tapasin Facilitates Folding of Major
                                                                  Histocompatibility Complex Class I
                                                                       Gustav Roder, Linda Geironson, Anna Darabi, Mikkel Harndahl, Claus Schafer-Nielsen, Karsten Skjødt, Søren Buus, Kajsa Paulsson
                                                                       Universities of Copenhagen, Lund, and Southern Denmark, and Schafer-N




Abstract
Tapasin is an ER chaperone that binds MHC-I molecules, integrates them into peptide-loading complexes, and exerts quality control of the bound peptides; only when an ’optimal peptide’ is bound
will the MHC-I be released and exported to the cell surface for presentation to T cells. The exact mechanisms of tapasin quality control and the criteria for being an optimal peptide are still unknown.
Here, we have generated a recombinant fragment of human tapasin, Tpn1-87 (representing the 87 N-terminal and ER-luminal amino acids of the mature tapasin protein), and found that Tpn1-87 spe-
cifically facilitates peptide dependent folding of HLA-A*0201. Furthermore, we used Tpn1-87 to generate a monoclonal antibody, αTpn1-87/80,, and its epitope was located to tapasin 40-44, which
maps to a surface-exposed loop on the tapasin structure.




Findings
The First 87 Amino Acids of tapasin Facilitates                                                                                                                                                                                          Natively Folded Wild-type tapasin Has a Surface
Folding of Peptide : HLA-A*0201 Complexes                                                                                                                                                                                                Exposed Loop Spanning Residues 40-44


Production of Recombinant Tpn1-87; The First 87 Amino Acids of tapasin                                                                                                                                                                   The Monoclonal Antibody, αTpn1-87/80, Recogizes Wild-Type tapasin


            A                                                                                                                                                                                                                                                                  A                                                                                   C
                                                                                                     7      71




                                                                                                                                                                                                                                                                                                      pn /19

                                                                                                                                                                                                                                                                                                       pn 7 /44

                                                                                                                                                                                                                                                                                                                                       0
                                                                                                         s-s                                                                           Length : 87 amino acids




                                                                                                                                                                                                                                                                                                       pn 4




                                                                                                                                                                                                                                                                                                                                   /8
                                                                                                                                                                                                                                                                                                    αT 1-87 /

                                                                                                                                                                                                                                                                                                    αT 1-87



                                                                                                                                                                                                                                                                                                                                  87
                                                                                             N                      C                                                                     MW : 9313.7 Da




                                                                                                                                                                                                                                                                                                                                            rt
                                                                                                                                                                                                                                                                                                    αT 1-8
                                                                                                                                                                                                                                                                                                 r




                                                                                                                                                                                                                                                                                                                                  1-
                                                                                                                                                                                                                                                                                              ke




                                                                                                                                                                                                                                                                                                                                           C
                                                 Tpn1-87 construct:




                                                                                                                                                                                                                                                                                                      pn
                                                                                                  Tpn1-87




                                                                                                                                                                                                                                                                                                                                        ti-
                                                                                                                                                                                                                                                                                            ar
                                                                                                                                                                                           pI : 8.0                                                                                                                                                                                    IP Sample: LCL-721.221A2




                                                                                                                                                                                                                                                                                                    αT




                                                                                                                                                                                                                                                                                                                                       an
                                                                                                                                                                                                                                                                                            M
                                                                                                     1         87
                                                                                                 Start              End
                                                                                                                                                                                                                                                                                  WB Sample: LCL-721.221A2                                                                                                          IP Fractions
                                                                                                                                   FXa                                                                                                                                          72 kDa
                                                                                                                                                          7     71
                                                                                                                                   IEGR                       s-s                      Length : 288 amino acids                                                                                                                                calreticulin
                                                                                             N                                                                           C                MW : 31563.1 Da                                                                                                                                                                                            Wash                      Elution
                       GrpE-Fxa-Tpn1-87 construct:                                                                  GrpE                                  Tpn1-87                                                                                                               56 kDa




                                                                                                                                                                                                                                                                                                                                                                                  r
                                                                                                                                                                                                                                                                                                                                                                               ke
                                                                                                                                                                                           pI : 5.0




                                                                                                                                                                                                                                                                                                                                                                                       ad
                                                                                                                                                                                                                                                                                                                                                                           ar
                                                                                                                                                                                                                                                                                                                                               wt-tapasin




                                                                                                                                                                                                                                                                                                                                                                                                   1
                                                                                                                                                                                                                                                                                                                                                                                                   2
                                                                                                                                                                                                                                                                                                                                                                                                   3
                                                                                                                                                                                                                                                                                                                                                                                             T
                                                                                                                                                                                                                                                                                                                                                                                                                        E1 E2 E3 E4 E5




                                                                                                                                                                                                                                                                                                                                                                                      Lo
                                                                                                     -201                           -5                    1         87




                                                                                                                                                                                                                                                                                                                                                                                                 W
                                                                                                                                                                                                                                                                                                                                                                                                 W
                                                                                                                                                                                                                                                                                                                                                                                                 W
                                                                                                                                                                                                                                                                                                                                                                           M




                                                                                                                                                                                                                                                                                                                                                                                            R
                                                                                                 Start                                                               End                                                                                                        43 kDa
                                                                                                                                                                                                                                                                                                                                                                       IP mAb: αTpn1-87/4
            B                                                                                                                                C                                                                                                                                                                                                                    56 kDa
                                         Anion Exchange Chromatography (AEX)                                                                                             Size Exclusion Chromatography (SEC)                                                                      WB Sample: LCL-721.220A2
                        700                                                                                                                                                                                                                                                     72 kDa                                                                                                                                                          wt-tapasin
                                                                                                                        100
                        600                                                      *4                                                                             1000                      1 *2                                                                                                                                                                    43 kDa
                                                                                                                        80                                       900                                                                                                                                                                           calreticulin
                        500                                                                                                                                      800                                                                                                            56 kDa
                                                                                                                                                                 700
             mAU




                        400                                                                                             60                                       600                                                                                                                                                                                                   IP mAb: αTpn1-87/80
                                                                                                                                                          mAU
                                                                                                                              %B




                                                                                                                                                                 500                                                                                                            43 kDa
                        300                  1   2 3                                                                    40                                       400                                                                                                                                                                                              56 kDa
                        200                                                                                                                                      300                                                                                                                                                                                                                                                                            wt-tapasin
                                                                                                                        20                                       200                                                                                                               WB Sample: GrpE-FXa-Tpn1-87
                        100
                                                                                                                                                                 100                                                                                                                                                                                              43 kDa
                                     0                                                                              0                                              0                                                                                                                                                                           GrpE-FXa-Tpn1-87
                                         0       500         1000       1500       2000       2500              3000                                                     0   25    50         75        100       125       150   175
                                                                    Volume [mL]                                                                                                           Volume [mL]
            D
                   Fermentation
                                                                        d
                                                                                            EAX Peak *4                                                                           SEC Peak 1                        SEC Peak *2                                                                 B
                                                         s          lve                                                                                                                                                                                                                                                       DAPI                     ERp57        αTpn1-87/80             Merged                         αGrpE/86
                                                       hr          o
                                               TG - 3          iss
                                          er
                                                                                                                                                                                                                                                                                                          LCL-721.221A2




                                                            D
                                      a rk o IP TG       ea
                                     M N IP           Ur                                   Fraction Samples                                                                                Fraction Samples



        66 kDa

        45 kDa
                                                                                                                                                                                                                                                                                                         LCL-721.220A2




        36 kDa

        29 kDa
        24 kDa

        20 kDa



                                                                                                     AEX pool                                                                                                                 SEC pool




                                                                                                                                                                                                                                         Mice were immunized with GrpE-FXa-Tpn1-87 and monoclonal antibodies were gen-
                                                                                                                                                                                                                                         erated. In Western blot, the antibodies recognized wild-type tapasin, and only in tapa-
 The GrpE-FXa-Tpn1-87 fusion protein (panel a) was expressed in E. coli BL21(DE3).                                                                                                                                                       sin positive cells (panel a). Both the ERp57 and αTpn1-87/80 antibodies stained areas
 GrpE-FXa-Tpn1-87 was purified by column chromatography in urea-containing buf-                                                                                                                                                          around the nucleus in the tapasin positive LCL-721.221A2 cells (panel b). Of all the
 fers; first by anion exchange chromatography (panels b,d) and then by size exclusion                                                                                                                                                    monoclonal antibodies that could recognize wild-type tapasin in Western blot, only
 chromatography (panels c,d).                                                                                                                                                                                                            one, αTpn1-87/80, could affinity purify wild-type, natively folded tapasin (panel c).



Tpn1-87 Facilitates Folding of Peptide : HLA-A*0201 Complexes                                                                                                                                                                            Wild-type tapasin Has a Surface Exposed Loop Spanning Residues 40-44
                                                        Peptide #1                                                                                                            Peptide #2
                                             RVNKGTGVK - HLA-A*0201                                                                                                 RIYSHIAPY - HLA-A*0201                                                  A                                                                                                    B                                                   C
                                     400                                                                             Ctrl                                 400                                                                Ctrl                                      120
                                                                                                                                                                                                                                                                                                                                                                                                                    7000
                                                                                                                                     % Folded MHC-I
                   % Folded MHC-I




                                     350                                                                                                                  350                                                                                                          110
                                                                                                                     GrpE                                                                                                    GrpE
                                                                                                                                                                                                                                             PeptideChip Signal [AU]




                                                                                                                                                                                                                                                                       100                                                                                                                                          6000
                                     300                                                                             GrpE-                                300                                                                GrpE-                                      90
                                                                                                                                                                                                                                                                                                                                                                                                                    5000
                                                                                                                                                                                                                                                                                                                                                                                                         LOCI CpS




                                     250                                                                                                                  250
HLA-A*0201                           200
                                                                                                                     FXa-
                                                                                                                     Tpn1-87                              200
                                                                                                                                                                                                                             FXa-
                                                                                                                                                                                                                             Tpn1-87
                                                                                                                                                                                                                                                                        80
                                                                                                                                                                                                                                                                        70
                                                                                                                                                                                                                                                                                                                                                                                                                    4000
                                                                                                                                                                                                                                                                        60
                                     150                                                                                                                  150                                                                                                           50                                                                                                                                          3000
                                     100                                                                                                                  100                                                                                                           40
                                                                                                                                                                                                                                                                        30                                                                                                                                          2000
                                      50                                                                                                                   50
                                                                                                                                                                                                                                                                        20                                                                                                                                          1000
                                       0 -2                                                                                                                 0 -2  -1 0             1       2        3         4         5                                               10
                                             -1 0                       1      2       3         4          5
                                        10 10 10                    10      10        10     10          10                                                  10 10 10             10     10        10     10       10                                                    0                                                                                                                                              0
                                                                                                                                                                              Peptide [nM]                                                                                                                                                                                                                              10-3   10-2      10-1   100   101    102   103
                                                              Peptide [nM]                                                                                                                                                                                                     Peptide Position in Tpn1-87 Sequence
                                                                                                                                                                                                                                                                                                                                                                                                                                      Peptide-23310 [nM]
                                                                                                                                                                                                                                                                             αTpn1-87/80:
                                                                                                                                                                                                                                                                                EPPPRPDLDPEL
                                                                                                                                                                                                                                                                                                                          LDPEL
                                     RVNKGTGVK - HLA-A*0201-T134K                                                                                             RIYSHIAPY - HLA-A*0201-T134K                                                                                             LDPELYLSVHDP

                                     400                                                                                                                  400
                    % Folded MHC-I




                                                                                                                     Ctrl                                                                                                    Ctrl
                                     350
                                                                                                                                         % Folded MHC-I




                                                                                                                     GrpE                                 350                                                                GrpE
                                     300                                                                             GrpE-                                300                                                                GrpE-
HLA-A*0201-                          250                                                                             FXa-                                 250                                                                FXa-
                                     200                                                                             Tpn1-87
T134K                                150
                                                                                                                                                          200
                                                                                                                                                          150
                                                                                                                                                                                                                             Tpn1-87

                                     100                                                                                                                  100
                                      50                                                                                                                   50
                                       0 -2  -1 0                       1      2       3         4          5                                               0 -2  -1 0             1       2        3         4         5
                                        10 10 10                    10      10        10     10          10                                                  10 10 10             10     10        10     10       10
                                                              Peptide [nM]                                                                                                    Peptide [nM]                                                A peptide microarray, consisting of sliding truncations of 12-mer peptides sliding
                                                                                                                                                                                                                                          along the GrpE-FXa-Tpn1-87 sequence with an overlap of 11 amino acids.,was incu-
                                                                                                                                                                                                                                          bated with αTpn1-87/80 monoclonal antibody, washed, stained with a Cy3 fluoro-
                                                                                                                                                                                                                                          chrome labeled secondary goat anti-mouse-IgG antiserum. The sliding truncations re-
                                                                                                                                                                                                                                          vealed a single strong signal peak centered on the sequence LDPEL corresponding to
 To examine whether GrpE-FXa-Tpn1-87 affected folding of HLA-A*0201, folded pep-                                                                                                                                                          human tapasin residues 40-44 (panel a). This region was mapped (loop shown in
 tide : HLA-A*0201 complexes were measured using a biochemical binding assay, with                                                                                                                                                        yellow) onto the protein structure of tapasin (panel b).
 or without GrpE-FXa-Tpn1-87. Two HLA-A*0201 binding peptides were examined.                                                                                                                                                              The αTpn1-87/80 interacting peptide (LDPELYLSVHD), was synthesized and could in-
 GrpE-FXa-Tpn1-87 increased the amount of folded HLA-A*0201, but no effect of GrpE                                                                                                                                                        hibit the recognition of GrpE-FXa-Tpn1-87 by αTpn1-87/80 in a biochemical assay.
 on the folding of HLA-A*0201 was observed indicating that Tpn1-87 is solely respon-                                                                                                                                                      (panel c). The IC50 value of this inhibition was 3 nM suggesting a very strong binding
 sible for facilitating peptide binding. Furthermore, a tapasin insentive mutant HLA-I                                                                                                                                                    between αTpn1-87/80 and GrpE-FXa-Tpn1-87.
 allele, HLA-A*0201-T134K, was also insensitive to Tpn1-87.




Conclusion #1                                                                                                                                                                                                                            Conclusion #2
 We conclude that Tpn1-87 is the active part of GrpE-FXa-Tpn1-87 affecting the folding                                                                                                                                                    In conclusion, αTpn1-87/80 recognizes a surface exposed, linear epitope consisting of
 of HLA-A*0201 and suggest that the specificity of this interaction resembles that of                                                                                                                                                     RPDLDPELYLS with a LDPEL core sequence.
 wild-type, full-length tapasin.

More Related Content

More from groder

Strategy Maps at Farvandsvaesenet, 2009
Strategy Maps at Farvandsvaesenet, 2009Strategy Maps at Farvandsvaesenet, 2009
Strategy Maps at Farvandsvaesenet, 2009groder
 
Strategikort I Farvandsvaesenet, 2009
Strategikort I Farvandsvaesenet, 2009Strategikort I Farvandsvaesenet, 2009
Strategikort I Farvandsvaesenet, 2009groder
 
Presentation at Immunologisk Selskab, 2006
Presentation at Immunologisk Selskab, 2006Presentation at Immunologisk Selskab, 2006
Presentation at Immunologisk Selskab, 2006groder
 
2D Barcode Tube System, Design a IT Process Platform
2D Barcode Tube System, Design a IT Process Platform2D Barcode Tube System, Design a IT Process Platform
2D Barcode Tube System, Design a IT Process Platformgroder
 
Peptide Chip for Antibody Epitope Mapping
Peptide Chip for Antibody Epitope MappingPeptide Chip for Antibody Epitope Mapping
Peptide Chip for Antibody Epitope Mappinggroder
 
Folding Recombinant MHC-I
Folding Recombinant MHC-IFolding Recombinant MHC-I
Folding Recombinant MHC-Igroder
 
MSc Defense, 2004
MSc Defense, 2004MSc Defense, 2004
MSc Defense, 2004groder
 
Curriculim Vitae, Gustav Roder
Curriculim Vitae, Gustav RoderCurriculim Vitae, Gustav Roder
Curriculim Vitae, Gustav Rodergroder
 

More from groder (8)

Strategy Maps at Farvandsvaesenet, 2009
Strategy Maps at Farvandsvaesenet, 2009Strategy Maps at Farvandsvaesenet, 2009
Strategy Maps at Farvandsvaesenet, 2009
 
Strategikort I Farvandsvaesenet, 2009
Strategikort I Farvandsvaesenet, 2009Strategikort I Farvandsvaesenet, 2009
Strategikort I Farvandsvaesenet, 2009
 
Presentation at Immunologisk Selskab, 2006
Presentation at Immunologisk Selskab, 2006Presentation at Immunologisk Selskab, 2006
Presentation at Immunologisk Selskab, 2006
 
2D Barcode Tube System, Design a IT Process Platform
2D Barcode Tube System, Design a IT Process Platform2D Barcode Tube System, Design a IT Process Platform
2D Barcode Tube System, Design a IT Process Platform
 
Peptide Chip for Antibody Epitope Mapping
Peptide Chip for Antibody Epitope MappingPeptide Chip for Antibody Epitope Mapping
Peptide Chip for Antibody Epitope Mapping
 
Folding Recombinant MHC-I
Folding Recombinant MHC-IFolding Recombinant MHC-I
Folding Recombinant MHC-I
 
MSc Defense, 2004
MSc Defense, 2004MSc Defense, 2004
MSc Defense, 2004
 
Curriculim Vitae, Gustav Roder
Curriculim Vitae, Gustav RoderCurriculim Vitae, Gustav Roder
Curriculim Vitae, Gustav Roder
 

Recently uploaded

Install Stable Diffusion in windows machine
Install Stable Diffusion in windows machineInstall Stable Diffusion in windows machine
Install Stable Diffusion in windows machinePadma Pradeep
 
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticsKotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticscarlostorres15106
 
Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Scott Keck-Warren
 
How to convert PDF to text with Nanonets
How to convert PDF to text with NanonetsHow to convert PDF to text with Nanonets
How to convert PDF to text with Nanonetsnaman860154
 
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhi
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | DelhiFULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhi
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhisoniya singh
 
Key Features Of Token Development (1).pptx
Key  Features Of Token  Development (1).pptxKey  Features Of Token  Development (1).pptx
Key Features Of Token Development (1).pptxLBM Solutions
 
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 3652toLead Limited
 
Designing IA for AI - Information Architecture Conference 2024
Designing IA for AI - Information Architecture Conference 2024Designing IA for AI - Information Architecture Conference 2024
Designing IA for AI - Information Architecture Conference 2024Enterprise Knowledge
 
Swan(sea) Song – personal research during my six years at Swansea ... and bey...
Swan(sea) Song – personal research during my six years at Swansea ... and bey...Swan(sea) Song – personal research during my six years at Swansea ... and bey...
Swan(sea) Song – personal research during my six years at Swansea ... and bey...Alan Dix
 
Making_way_through_DLL_hollowing_inspite_of_CFG_by_Debjeet Banerjee.pptx
Making_way_through_DLL_hollowing_inspite_of_CFG_by_Debjeet Banerjee.pptxMaking_way_through_DLL_hollowing_inspite_of_CFG_by_Debjeet Banerjee.pptx
Making_way_through_DLL_hollowing_inspite_of_CFG_by_Debjeet Banerjee.pptxnull - The Open Security Community
 
"LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks...
"LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks..."LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks...
"LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks...Fwdays
 
Build your next Gen AI Breakthrough - April 2024
Build your next Gen AI Breakthrough - April 2024Build your next Gen AI Breakthrough - April 2024
Build your next Gen AI Breakthrough - April 2024Neo4j
 
CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):comworks
 
SQL Database Design For Developers at php[tek] 2024
SQL Database Design For Developers at php[tek] 2024SQL Database Design For Developers at php[tek] 2024
SQL Database Design For Developers at php[tek] 2024Scott Keck-Warren
 
Human Factors of XR: Using Human Factors to Design XR Systems
Human Factors of XR: Using Human Factors to Design XR SystemsHuman Factors of XR: Using Human Factors to Design XR Systems
Human Factors of XR: Using Human Factors to Design XR SystemsMark Billinghurst
 
Understanding the Laravel MVC Architecture
Understanding the Laravel MVC ArchitectureUnderstanding the Laravel MVC Architecture
Understanding the Laravel MVC ArchitecturePixlogix Infotech
 
"Federated learning: out of reach no matter how close",Oleksandr Lapshyn
"Federated learning: out of reach no matter how close",Oleksandr Lapshyn"Federated learning: out of reach no matter how close",Oleksandr Lapshyn
"Federated learning: out of reach no matter how close",Oleksandr LapshynFwdays
 
Are Multi-Cloud and Serverless Good or Bad?
Are Multi-Cloud and Serverless Good or Bad?Are Multi-Cloud and Serverless Good or Bad?
Are Multi-Cloud and Serverless Good or Bad?Mattias Andersson
 
My Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 PresentationMy Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 PresentationRidwan Fadjar
 
Benefits Of Flutter Compared To Other Frameworks
Benefits Of Flutter Compared To Other FrameworksBenefits Of Flutter Compared To Other Frameworks
Benefits Of Flutter Compared To Other FrameworksSoftradix Technologies
 

Recently uploaded (20)

Install Stable Diffusion in windows machine
Install Stable Diffusion in windows machineInstall Stable Diffusion in windows machine
Install Stable Diffusion in windows machine
 
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticsKotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
 
Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024
 
How to convert PDF to text with Nanonets
How to convert PDF to text with NanonetsHow to convert PDF to text with Nanonets
How to convert PDF to text with Nanonets
 
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhi
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | DelhiFULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhi
FULL ENJOY 🔝 8264348440 🔝 Call Girls in Diplomatic Enclave | Delhi
 
Key Features Of Token Development (1).pptx
Key  Features Of Token  Development (1).pptxKey  Features Of Token  Development (1).pptx
Key Features Of Token Development (1).pptx
 
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
Tech-Forward - Achieving Business Readiness For Copilot in Microsoft 365
 
Designing IA for AI - Information Architecture Conference 2024
Designing IA for AI - Information Architecture Conference 2024Designing IA for AI - Information Architecture Conference 2024
Designing IA for AI - Information Architecture Conference 2024
 
Swan(sea) Song – personal research during my six years at Swansea ... and bey...
Swan(sea) Song – personal research during my six years at Swansea ... and bey...Swan(sea) Song – personal research during my six years at Swansea ... and bey...
Swan(sea) Song – personal research during my six years at Swansea ... and bey...
 
Making_way_through_DLL_hollowing_inspite_of_CFG_by_Debjeet Banerjee.pptx
Making_way_through_DLL_hollowing_inspite_of_CFG_by_Debjeet Banerjee.pptxMaking_way_through_DLL_hollowing_inspite_of_CFG_by_Debjeet Banerjee.pptx
Making_way_through_DLL_hollowing_inspite_of_CFG_by_Debjeet Banerjee.pptx
 
"LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks...
"LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks..."LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks...
"LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks...
 
Build your next Gen AI Breakthrough - April 2024
Build your next Gen AI Breakthrough - April 2024Build your next Gen AI Breakthrough - April 2024
Build your next Gen AI Breakthrough - April 2024
 
CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):
 
SQL Database Design For Developers at php[tek] 2024
SQL Database Design For Developers at php[tek] 2024SQL Database Design For Developers at php[tek] 2024
SQL Database Design For Developers at php[tek] 2024
 
Human Factors of XR: Using Human Factors to Design XR Systems
Human Factors of XR: Using Human Factors to Design XR SystemsHuman Factors of XR: Using Human Factors to Design XR Systems
Human Factors of XR: Using Human Factors to Design XR Systems
 
Understanding the Laravel MVC Architecture
Understanding the Laravel MVC ArchitectureUnderstanding the Laravel MVC Architecture
Understanding the Laravel MVC Architecture
 
"Federated learning: out of reach no matter how close",Oleksandr Lapshyn
"Federated learning: out of reach no matter how close",Oleksandr Lapshyn"Federated learning: out of reach no matter how close",Oleksandr Lapshyn
"Federated learning: out of reach no matter how close",Oleksandr Lapshyn
 
Are Multi-Cloud and Serverless Good or Bad?
Are Multi-Cloud and Serverless Good or Bad?Are Multi-Cloud and Serverless Good or Bad?
Are Multi-Cloud and Serverless Good or Bad?
 
My Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 PresentationMy Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 Presentation
 
Benefits Of Flutter Compared To Other Frameworks
Benefits Of Flutter Compared To Other FrameworksBenefits Of Flutter Compared To Other Frameworks
Benefits Of Flutter Compared To Other Frameworks
 

The N-Terminal Region of tapasin Facilitates Folding of MHC-I

  • 1. The Outermost N-Terminal Region of tapasin Facilitates Folding of Major Histocompatibility Complex Class I Gustav Roder, Linda Geironson, Anna Darabi, Mikkel Harndahl, Claus Schafer-Nielsen, Karsten Skjødt, Søren Buus, Kajsa Paulsson Universities of Copenhagen, Lund, and Southern Denmark, and Schafer-N Abstract Tapasin is an ER chaperone that binds MHC-I molecules, integrates them into peptide-loading complexes, and exerts quality control of the bound peptides; only when an ’optimal peptide’ is bound will the MHC-I be released and exported to the cell surface for presentation to T cells. The exact mechanisms of tapasin quality control and the criteria for being an optimal peptide are still unknown. Here, we have generated a recombinant fragment of human tapasin, Tpn1-87 (representing the 87 N-terminal and ER-luminal amino acids of the mature tapasin protein), and found that Tpn1-87 spe- cifically facilitates peptide dependent folding of HLA-A*0201. Furthermore, we used Tpn1-87 to generate a monoclonal antibody, αTpn1-87/80,, and its epitope was located to tapasin 40-44, which maps to a surface-exposed loop on the tapasin structure. Findings The First 87 Amino Acids of tapasin Facilitates Natively Folded Wild-type tapasin Has a Surface Folding of Peptide : HLA-A*0201 Complexes Exposed Loop Spanning Residues 40-44 Production of Recombinant Tpn1-87; The First 87 Amino Acids of tapasin The Monoclonal Antibody, αTpn1-87/80, Recogizes Wild-Type tapasin A A C 7 71 pn /19 pn 7 /44 0 s-s Length : 87 amino acids pn 4 /8 αT 1-87 / αT 1-87 87 N C MW : 9313.7 Da rt αT 1-8 r 1- ke C Tpn1-87 construct: pn Tpn1-87 ti- ar pI : 8.0 IP Sample: LCL-721.221A2 αT an M 1 87 Start End WB Sample: LCL-721.221A2 IP Fractions FXa 72 kDa 7 71 IEGR s-s Length : 288 amino acids calreticulin N C MW : 31563.1 Da Wash Elution GrpE-Fxa-Tpn1-87 construct: GrpE Tpn1-87 56 kDa r ke pI : 5.0 ad ar wt-tapasin 1 2 3 T E1 E2 E3 E4 E5 Lo -201 -5 1 87 W W W M R Start End 43 kDa IP mAb: αTpn1-87/4 B C 56 kDa Anion Exchange Chromatography (AEX) Size Exclusion Chromatography (SEC) WB Sample: LCL-721.220A2 700 72 kDa wt-tapasin 100 600 *4 1000 1 *2 43 kDa 80 900 calreticulin 500 800 56 kDa 700 mAU 400 60 600 IP mAb: αTpn1-87/80 mAU %B 500 43 kDa 300 1 2 3 40 400 56 kDa 200 300 wt-tapasin 20 200 WB Sample: GrpE-FXa-Tpn1-87 100 100 43 kDa 0 0 0 GrpE-FXa-Tpn1-87 0 500 1000 1500 2000 2500 3000 0 25 50 75 100 125 150 175 Volume [mL] Volume [mL] D Fermentation d EAX Peak *4 SEC Peak 1 SEC Peak *2 B s lve DAPI ERp57 αTpn1-87/80 Merged αGrpE/86 hr o TG - 3 iss er LCL-721.221A2 D a rk o IP TG ea M N IP Ur Fraction Samples Fraction Samples 66 kDa 45 kDa LCL-721.220A2 36 kDa 29 kDa 24 kDa 20 kDa AEX pool SEC pool Mice were immunized with GrpE-FXa-Tpn1-87 and monoclonal antibodies were gen- erated. In Western blot, the antibodies recognized wild-type tapasin, and only in tapa- The GrpE-FXa-Tpn1-87 fusion protein (panel a) was expressed in E. coli BL21(DE3). sin positive cells (panel a). Both the ERp57 and αTpn1-87/80 antibodies stained areas GrpE-FXa-Tpn1-87 was purified by column chromatography in urea-containing buf- around the nucleus in the tapasin positive LCL-721.221A2 cells (panel b). Of all the fers; first by anion exchange chromatography (panels b,d) and then by size exclusion monoclonal antibodies that could recognize wild-type tapasin in Western blot, only chromatography (panels c,d). one, αTpn1-87/80, could affinity purify wild-type, natively folded tapasin (panel c). Tpn1-87 Facilitates Folding of Peptide : HLA-A*0201 Complexes Wild-type tapasin Has a Surface Exposed Loop Spanning Residues 40-44 Peptide #1 Peptide #2 RVNKGTGVK - HLA-A*0201 RIYSHIAPY - HLA-A*0201 A B C 400 Ctrl 400 Ctrl 120 7000 % Folded MHC-I % Folded MHC-I 350 350 110 GrpE GrpE PeptideChip Signal [AU] 100 6000 300 GrpE- 300 GrpE- 90 5000 LOCI CpS 250 250 HLA-A*0201 200 FXa- Tpn1-87 200 FXa- Tpn1-87 80 70 4000 60 150 150 50 3000 100 100 40 30 2000 50 50 20 1000 0 -2 0 -2 -1 0 1 2 3 4 5 10 -1 0 1 2 3 4 5 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 0 0 Peptide [nM] 10-3 10-2 10-1 100 101 102 103 Peptide [nM] Peptide Position in Tpn1-87 Sequence Peptide-23310 [nM] αTpn1-87/80: EPPPRPDLDPEL LDPEL RVNKGTGVK - HLA-A*0201-T134K RIYSHIAPY - HLA-A*0201-T134K LDPELYLSVHDP 400 400 % Folded MHC-I Ctrl Ctrl 350 % Folded MHC-I GrpE 350 GrpE 300 GrpE- 300 GrpE- HLA-A*0201- 250 FXa- 250 FXa- 200 Tpn1-87 T134K 150 200 150 Tpn1-87 100 100 50 50 0 -2 -1 0 1 2 3 4 5 0 -2 -1 0 1 2 3 4 5 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 Peptide [nM] Peptide [nM] A peptide microarray, consisting of sliding truncations of 12-mer peptides sliding along the GrpE-FXa-Tpn1-87 sequence with an overlap of 11 amino acids.,was incu- bated with αTpn1-87/80 monoclonal antibody, washed, stained with a Cy3 fluoro- chrome labeled secondary goat anti-mouse-IgG antiserum. The sliding truncations re- vealed a single strong signal peak centered on the sequence LDPEL corresponding to To examine whether GrpE-FXa-Tpn1-87 affected folding of HLA-A*0201, folded pep- human tapasin residues 40-44 (panel a). This region was mapped (loop shown in tide : HLA-A*0201 complexes were measured using a biochemical binding assay, with yellow) onto the protein structure of tapasin (panel b). or without GrpE-FXa-Tpn1-87. Two HLA-A*0201 binding peptides were examined. The αTpn1-87/80 interacting peptide (LDPELYLSVHD), was synthesized and could in- GrpE-FXa-Tpn1-87 increased the amount of folded HLA-A*0201, but no effect of GrpE hibit the recognition of GrpE-FXa-Tpn1-87 by αTpn1-87/80 in a biochemical assay. on the folding of HLA-A*0201 was observed indicating that Tpn1-87 is solely respon- (panel c). The IC50 value of this inhibition was 3 nM suggesting a very strong binding sible for facilitating peptide binding. Furthermore, a tapasin insentive mutant HLA-I between αTpn1-87/80 and GrpE-FXa-Tpn1-87. allele, HLA-A*0201-T134K, was also insensitive to Tpn1-87. Conclusion #1 Conclusion #2 We conclude that Tpn1-87 is the active part of GrpE-FXa-Tpn1-87 affecting the folding In conclusion, αTpn1-87/80 recognizes a surface exposed, linear epitope consisting of of HLA-A*0201 and suggest that the specificity of this interaction resembles that of RPDLDPELYLS with a LDPEL core sequence. wild-type, full-length tapasin.